Business Wire

NY-WINSTON-&-STRAWN

Share
U.S. Ambassador to Spain and Andorra Julissa Reynoso Rejoins Winston & Strawn

Winston & Strawn LLP announced today the return of Julissa Reynoso as a partner in the firm’s New York office and as a member of its Litigation Department. Julissa is an experienced diplomat, policymaker, and lawyer, and was a Winston partner from July 2017 to December 2020.

She rejoins the firm after serving as U.S. Ambassador to Spain and Andorra from January 2022 to July 2024, the first woman to hold the position.

In her role as Ambassador, Julissa oversaw a critical U.S. mission with a host of U.S. federal agencies covering economic, political, and defense and security matters. She was a tireless advocate for American companies doing business in Spain, and supported historic levels of investment by Spanish companies in the United States. During her tenure, Spain served as host of the 2022 NATO Summit and held the presidency of the Council of the European Union.

Prior to being confirmed as Ambassador, Julissa served in senior positions at the White House, including as Assistant to the President and Chief of Staff to Dr. Jill Biden. In those roles, she managed a range of domestic and international matters and served as Co-Chair of the Gender Policy Council, the first policy council focused on gender equity and equality within the Executive Office of the President.

During the Obama Administration, Julissa served as Deputy Assistant Secretary of State in the Bureau of Western Hemisphere Affairs and later as the U.S. Ambassador to Uruguay.

“During my three years as a partner at Winston, I witnessed the incredible talent, creativity, and the depth of knowledge of my colleagues, each committed to the firm’s diverse roster of global clients,” said Julissa. “It is an exciting time to rejoin the firm, and I look forward to supporting the new leadership team by helping to grow the firm’s global client base.”

Julissa will focus on complex commercial litigation, regulatory enforcement, international arbitration, and cross-border disputes. She will provide U.S. and international clients with strategic advice and risk assessment in managing transnational issues.

“Julissa’s exceptional background in international relations will add considerable value for Winston’s clients,” said Peter Crowther, managing partner, international affairs. “Her ties to international clients will also be instrumental in advising their businesses throughout the world including in the United States.”

“We have followed Julissa’s accomplishments in government service with the utmost pride and are privileged to welcome her back to Winston,” said Winston Chairman Steve D’Amore. “Julissa is a prime example of the global talent Winston has attracted through a culture built on cross-practice collaboration, mentorship, and client focus. Thinking and acting as a single global unit is a strategic priority for Winston, and Julissa will be an integral part of that journey.”

Winston & Strawn LLP is an international law firm with 15 offices in North America, South America, Europe, and Asia. More information about the firm is available at www.winston.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240716496853/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 202513.10.2025 01:31:00 CEST | Press release

Results from the Phase 1b dose escalation of the TheraPb Phase 1/2 trial are the first clinical data for a Lead-212 (212Pb)-based-PSMA radioligand therapy The abstract presents a favorable safety profile for 212Pb-ADVC001 and promising anti-tumor activity, underscoring its potential to enhance therapeutic options for patients with metastatic prostate cancer The upcoming presentation at ESMO will feature updated safety and efficacy results from all seven Phase 1b treatment cohorts AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, announces a presentation at the European Society for Medical Oncology (ESMO) Congress, taking place in Berlin, Germany, from October 17-21, 2025. The presentation will feature promising results from the Phase 1b dose escalation of the Phase 1/2 TheraPb study, evaluating ADVC001, a Lead-212-based PSMA-targeted alpha therapy, in metastatic castration-resistant prostate cancer (mCRPC). This will be t

Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 202513.10.2025 00:05:00 CEST | Press release

Incyte (Nasdaq:INCY) today announced that results from Phase 1 proof-of-concept studies of INCA33890, a promising TGFβR2×PD-1-directed bispecific antibody, and INCB161734, a novel, selective and orally bioavailable KRAS G12D inhibitor, will be highlighted as oral presentations at the upcoming European Society of Medical Oncology (ESMO) Congress 2025 in Berlin. “We are encouraged by the positive findings being presented with our TGFβR2×PD-1 and KRAS G12D inhibitor programs, which validate our rationale for advancing the development of these novel investigational compounds," said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. "There remains a significant need for new treatment options for patients with advanced solid tumors like colorectal cancer and pancreatic ductal adenocarcinoma and we look forward to providing updates on these clinical development programs.” Details on INCA33890 and INCB161734 oral presentations at ESMO include: INCA33890 (PD-1/TGFβR

Day Two of the 11th World FZO Congress Highlights the Role of Digitization and Sustainability in Shaping the Future of Free Zones11.10.2025 16:52:00 CEST | Press release

The World Free Zones Organization’s 11th annual World Congress continued its agenda today with a focus on the role of digitization and sustainability in the future of free zones and the mechanisms for enhancing their position as strategic trade gateways. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251011933300/en/ Dr Al Zarooni and President of CIRD launching the global institute (Photo: AETOSWire) The day’s sessions featured a series of sessions addressing critical themes such as the digitization of trade corridors, the impact of the OECD Global Minimum Tax, and the role of free zones as regional trade gateways. Sustainability took centre stage with sessions focusing on the transition to net-zero through renewable energy, circular economy models, and green financing frameworks. Speakers underscored that decarbonization is not only a climate imperative but also a competitive advantage for the next generation of free zones

IonQ to Participate in ComoLake2025, Advancing Quantum Collaboration in Italy10.10.2025 22:05:00 CEST | Press release

IonQ CEO to discuss how quantum accelerates innovation and economic growth at Italy’s leading tech and policy forum IonQ (NYSE: IONQ), a leading quantum company, today announced its participation in the ComoLake2025 Digital Innovation Forum, one of Italy’s most prominent technology events focused on digital transformation, infrastructure, and innovation policy. At ComoLake2025, taking place October 14–17 at the Villa Erba International Exhibition and Congress Center in Cernobbio, Niccolò de Masi, Chairman and CEO at IonQ, will deliver a special address, offering strategic insights into how quantum computing is reshaping infrastructure, industry, and Europe’s digital leadership. Marco Pistoia, Senior Vice President of Industry Relations at IonQ, will participate in the round table “Pan-European Quantum Industry Forum - Dialogue between Industry, Politics, and Research for Europe's Quantum Leadership” focused on strengthening Europe’s position in the global quantum landscape. Organized b

IonQ to Participate in GITEX Dubai 2025, Showcasing Advancements in Quantum Infrastructure and Security10.10.2025 22:05:00 CEST | Press release

Executives at IonQ and ID Quantique to address the future of quantum-safe infrastructure and cloud platforms at one of the world’s largest tech events IonQ (NYSE: IONQ), a leading quantum company, today announced its participation in GITEX Global 2025, one of the world’s largest and most influential technology exhibitions, taking place October 13-17 at the Dubai World Trade Centre. IonQ executives and partners will highlight advancements in quantum computing, secure infrastructure, and commercial applications that are accelerating enterprise adoption of quantum technologies. Rima Alameddine, Chief Revenue Officer at IonQ, will speak on the panel “Cracking the Quantum Code: How to Build a Profitable Business in the Quantum Economy,” on October 14, in Hall 10, AI stage. This session will convene global quantum leaders to discuss the path from breakthrough science to viable commercial success, including how to unlock investment, scale quantum solutions, and deliver near-term value across

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye